3.95
-0.0376(-0.94%)
Currency In USD
| Previous Close | 3.99 |
| Open | 3.97 |
| Day High | 3.99 |
| Day Low | 3.95 |
| 52-Week High | 100.8 |
| 52-Week Low | 2.77 |
| Volume | 8,288 |
| Average Volume | 1.86M |
| Market Cap | 8.5M |
| PE | -0.24 |
| EPS | -16.41 |
| Moving Average 50 Days | 4.32 |
| Moving Average 200 Days | 8.4 |
| Change | -0.04 |
If you invested $1000 in HCW Biologics Inc. (HCWB) since IPO date, it would be worth $633.33 as of October 20, 2025 at a share price of $3.99. Whereas If you bought $1000 worth of HCW Biologics Inc. (HCWB) shares 3 years ago, it would be worth $44.73 as of October 20, 2025 at a share price of $3.99.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
HCW Biologics to Participate in the 2025 Maxim Growth Summit
GlobeNewswire Inc.
Oct 16, 2025 1:25 PM GMT
MIRAMAR, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to extend healthspan by targe
HCW Biologics’ Scientists to Present Three Posters During the 40th Annual Meeting of the Society for Immunotherapy of Cancer
GlobeNewswire Inc.
Oct 16, 2025 1:15 PM GMT
Company poster presentations will debut research data of three lead drug candidates constructed with Company’s novel TRBC platform technologyMIRAMAR, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB
HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment About its Proprietary T-Cell Engager Program
GlobeNewswire Inc.
Sep 30, 2025 12:45 PM GMT
Watch the "What This Means" video here Featuring Company’s second-generation T-Cell Engager program and advantages over first-generation Company’s T-Cell Engager program has made improvements in manufacturability, preclinical safety profile, and abil